Global prescription sales up 6.4%: IMS Health

According to an IMS Health report, global prescription sales topped $712 billion in 2007, a 6.4% growth.

The US remains the single largest market, at $286.5 billion, despite its “lowest-ever level” of contribution to global growth in 2007, at 25.5%.  Total prescription sales in the US grew 3.8%, according to the report.

Asian (excluding Japan, including Australia and New Zealand) and Latin American markets saw the most expansion last year, posting 13.3% and 11.6% growths respectively.  China grew by 25.7%.

In the US, lipid regulators for cholesterol were the top-selling therapeutic class, at $18.4 billion, while anti-depressants represented the largest therapeutic class by dispensed prescriptions, at 232.7 million, according to the IMS data.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions